Further Decline of Trans Fatty Acids Levels Among US Adults Between 1999-2000 and 2009-2010.

Am J Public Health

Brandon J. Restrepo is with the Economic Research Service, US Department of Agriculture, Washington, DC.

Published: January 2017

Objectives: To investigate differences in levels of plasma trans fatty acids (TFAs) and a broad set of other markers for cardiovascular disease (CVD) risk in the US adult population between 1999-2000 and 2009-2010.

Methods: Using a nationally representative sample of US adults aged 20 years and older from the 1999-2000 and 2009-2010 waves of the National Health and Nutrition Examination Survey, regression models were estimated to compare levels of TFAs and other markers for CVD risk over time.

Results: Significant declines in levels of plasma TFAs and improvements in a variety of other markers for CVD risk were observed in the US adult population.

Conclusions: Between the 2 time points, 1999-2000 and 2009-2010, there were substantial decreases in TFA levels and improvements in several other important cardiovascular health indicators in US adults.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308168PMC
http://dx.doi.org/10.2105/AJPH.2016.303524DOI Listing

Publication Analysis

Top Keywords

1999-2000 2009-2010
12
cvd risk
12
trans fatty
8
fatty acids
8
levels plasma
8
markers cvd
8
levels
5
decline trans
4
acids levels
4
levels adults
4

Similar Publications

Objective: While earlier research has indicated that trans fatty acids (TFAs) are detrimental to cardiovascular health as well as other conditions, the purpose of this study is to look into any possible connections between trans fatty acids and rheumatoid arthritis (RA).

Methods: The NHANES database provided the data for this study, covering two periods: 1999-2000 and 2009-2010. The correlation between plasma TFAs (linolelaidic acid, vaccenic acid, palmitelaidic acid, and elaidic acid) and RA was examined using weighted univariate and multivariate regression analyses as well as analysis of subgroups.

View Article and Find Full Text PDF

Trends in ovarian cancer net survival in a northeastern Brazilian state (1996-2017).

Cancer Epidemiol

December 2024

Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil; Aracaju Cancer Registry, Aracaju, Sergipe, Brazil; University Hospital, Ebserh, Federal University of Sergipe, Aracaju, Sergipe, Brazil. Electronic address:

Background: Ovarian cancer survival in low- and middle-income countries is lower than in high-income countries, due to disparities in healthcare access and socioeconomic factors. This study aimed to describe trends in ovarian cancer survival in Sergipe, Northeast Brazil, by histological group.

Methods: We analysed data on 948 women aged 15-99 years diagnosed with a cancer of the ovary between 1996 and 2017, in Sergipe, Brazil.

View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed trends in waitlisting, re-transplantation, and mortality rates among U.S. kidney transplant patients whose first graft failed, using data from the United States Renal Data System between 1990 and 2019.
  • - Results showed that while the number of patients starting dialysis after graft failure increased, the rate of waitlisting for second transplants initially rose but later fell, and re-transplantation rates consistently decreased across the years.
  • - Notably, there were disparities in outcomes based on gender and race, with women and minority groups (African-American and Hispanic patients) experiencing lower rates of waitlisting and re-transplantation compared to men and White patients.
View Article and Find Full Text PDF
Article Synopsis
  • * The incidence of this breast cancer type rose from 70 to 113 per 100,000 women over the 29 years, with improvements in survival rates over time due to advancements in treatment methods.
  • * Women diagnosed between 2015-2019 had a significantly lower risk of death compared to those diagnosed in the early '90s, highlighting the effectiveness of modern therapies like endocrine treatment in enhancing patient outcomes.
View Article and Find Full Text PDF

Tracking the Helicobacter pylori Epidemic in Adults and Children in China.

Helicobacter

September 2024

Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Peking University People's Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People's Hospital, Beijing, China.

Background: The Helicobacter pylori epidemic in China accounts for up to a third of gastric cancers worldwide. We aim to monitor the temporal and spatial dynamics of H. pylori infection in both adults and children across China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!